NDC 52959-910-30 - Hypertenipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-910
- Requested NDC
- 52959-910-30
- Package NDCs from labels
- 52959-910-30
- Manufacturer
- Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hypertenipine-2.5 | Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-910-30 | Hypertenipine | 30 in 1 BOTTLE | TABLET | 30 | 2.5 mg | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | f77db79c-c998-4b63-9984-4cf245f188a7 | 2023-09-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d830173d-7676-4490-ab3d-d3515df9ad2e | 2023-09-07 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 5dfcba1f-91c4-4ca5-8a98-fc4fdb2f7ee1 | 2023-09-07 | Warnings, Adverse reactions | ANDA077955 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 69a887ab-95cd-4b81-80ee-02e20eebf65b | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Azor | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | c5535406-b63b-49aa-88b9-169aaf0ed08e | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| A L O Formula | CHOLINUM, L-ARGININE, L-CARNITINE, L-ORNITHINE, PANTOTHENIC ACID | Nutritional Specialties, Inc. | 0df7e08c-c17f-4e5e-acfd-05f8af7277cc | 2023-07-07 | Warnings | 94ZLA3W45F |
| Vital Skin Hair Nails | L-ALANINE, L-ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, APIS MELLIFICA, BIOTIN, EPIDERMIS SUIS, GALIUM APARINE, HAMAMELIS VIRGINIANA, HEPAR SUIS, HGH, HYPOPHYSIS SUIS, NATRUM MURIATICUM, PANTOTHENIC ACID, PHOSPHORICUM ACIDUM, RIBOFLAVINUM, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 3e8a9233-6e65-4023-b3f8-8bca369a9c2a | 2023-06-15 | Warnings | 94ZLA3W45F |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | ced6d26e-8c54-4808-88b6-446344f4acd0 | 2023-06-01 | Warnings, Adverse reactions | 308136 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 186b6149-9610-4380-9bf2-941646069276 | 2023-05-04 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | BluePoint Laboratories | df8e23c8-6c8f-4293-8a37-5ad3d48dba94 | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | b597d1e1-aba1-4272-bed7-4c95e8150d58 | 2023-04-19 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Exelan Pharmaceuticals, Inc. | efd9eda5-f497-45a3-ae13-dee729add999 | 2023-03-23 | Warnings, Adverse reactions | ANDA077955 308136 864V2Q084H |
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | 308136 864V2Q084H |
| CellTropin | ARGININE, GINKGO BILOBA, HYPOPHYSIS SUIS, SILICEA, ASTRAGALUS EXCAPUS | Micro Balance Health Products LLC | 502d3ffa-bbf4-403a-9fad-b6b229f36a8c | 2023-02-14 | Warnings | 94ZLA3W45F |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Limited | a9c442dc-749e-4de0-bca3-1044eb78da72 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Limited | cb2df7f7-fee8-42ba-8936-0788c4fcc0cb | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | f12f18bb-7ddb-e7dc-4edd-32f4ac212bca | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | ca014f06-982c-6fe1-9948-a3701dd35d34 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.